Trials / Terminated
TerminatedNCT01522716
Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Karolinska Institutet · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate the safety and efficacy of mesenchymal stromal cells as treatment for steroid-refractory chronic graft-versus-host disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Mesenchymal stromal cells | Allogenous mesenchymal stromal cells, to be injected intravenously at a dose of 1-2 million/kg at a frequency of once a month (frequency may be changed during the study if deemed appropriate by investigators) for 6-9 months. |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2016-03-01
- Completion
- 2017-03-01
- First posted
- 2012-02-01
- Last updated
- 2020-11-25
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01522716. Inclusion in this directory is not an endorsement.